RMD insider trading
HealthcareRESMED INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About RESMED INC
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Company website: www.resmed.com
RMD insider activity at a glance
FilingIQ has scored 1,545 insider transactions for RMD since Jan 26, 2015. The most recent filing in our index is dated May 7, 2026.
Across the full history, 1 open-market purchases
and 582 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on RMD insider trades is 67.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest RMD Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding RMD
Politicians who have traded RMD
Frequently asked
- How many insider trades does FilingIQ track for RMD?
- FilingIQ tracks 1,545 Form 4 insider transactions for RMD (RESMED INC), covering filings from Jan 26, 2015 onwards. 13 of those were filed in the last 90 days.
- Are RMD insiders net buyers or net sellers?
- Across the full Form 4 history for RMD, 1 transactions (0%) were open-market purchases and 582 (38%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does RMD insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is RMD in?
- RESMED INC (RMD) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $36.86B.
Methodology & sources
Every RMD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.